Summary: Bladder cancer is found among people who take Losartan, especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years. Update [6/26/2019] FDA is alerting patients and health care professionals to Macleods Pharmaceuticals’ voluntary recall of two lots of losartan potassium tablets (50mg strength) and 30 lots of losartan potassium/hydrochlorothiazide (HCTZ) combination tablets (12 lots of 50mg/12.5mg strength, three lots of 100mg/12.5mg strength, and 15 lots of 100mg/25mg … MedWatch Safety Alerts are distributed by the FDA and published by Drugs.com. The expanded recall includes an additional three lots of losartan potassium tablets USP and two lots of losartan potassium/ydrochlorothiazide … ©2021 FOX News Network, LLC. Madeline Farber is a Reporter for Fox News. In July, drug companies began recalling dozens of lots of the blood pressure and heart medications called valsartan, losartan and irbesartan after … Valsartan, Irbesartan, and Losartan are among the most commonly prescribed drugs for treating high blood pressure and heart failure. The contaminated medication was not distributed before Oct. 8. Individuals who used these drugs and were diagnosed with cancer may be eligible for … On Sept. 23, 2019 the Food and Drug Administration issued a voluntary nationwide Search List of Recalled Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan. Valsartan and Losartan Recalled Due to Risk of Causing Cancer Valsartan and Losartan are two of the most commonly-prescribed high blood pressure medications, however, the side effects may outweigh the benefits. NDEA can cause cancer, even in small amounts. Powered and implemented by FactSet Digital Solutions. The company said the recall only affects products found to have more than the FDA-allowable amount of NMBA. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan due to an "impurity" that may pose a cancer risk. This prompted the first recall of valsartan medicines due to the presence of a cancer-causing substance called N-nitrosodimethylamine (NDMA) in July 2018. We are highly experienced losartan cancer attorneys who will answer your questions related to your irbesartan recall lawsuit, helping you navigate the issues associated with an amlodipine lawsuit. Losartan Recall – What is the Cancer-Causing Ingredient It was indicated that Losartan tablets contain N-methylnitrosobutyric acid (NMBA). The FDA launched an investigation to determine the cause and impact of the valsartan contamination. What you should do Media enquiries Public enquiries March 9, 2019 For immediate release. Market data provided by Factset. The company stated that the affected products found to include more NMBA than the FDA allowed. The recall of a widely-prescribed blood pressure drug losartan is being expanded again by the Food and Drug Administration due to contamination by cancer-linked chemical. The news marks the fifth time the company has expanded the recall. This recall … The FDA Alert(s) below may be specifically about losartan or relate to a group or class of drugs which include losartan. The recall involves losartan and potassium/hydrochlorothiazide combination pills found to contain N-Nitroso-N-methyl-4-aminobutyric acid, or NMBA, according to a … A recall on losartan medications soon followed. Company Announcement. “FDA is alerting patients and health care professionals to Sandoz’s voluntary recall of one lot – JB8912 – of losartan potassium and hydrochlorothiazide 100mg/25mg tablets, that contain losartan, an angiotensin II receptor blocker (ARB), and hydrochlorothiazide, a diuretic, used in combination for the treatment of hypertension. A recall for blood pressure drugs has been expanded. This material may not be published, broadcast, rewritten, or redistributed. Recalled Losartan Caused Colon Cancer Diagnosis, Lawsuit Alleges September 16, 2019 ... Side effects of Belviq may increase the risk of cancer, resulting in a diet drug recall and lawsuits. Note: This story was updated on Sept. 23, 2019, with an additional losartan recall from Torrent Pharmaceuticals. Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Losartan potassium tablets sold by Macleods Pharmaceuticals were recalled after trace amounts of a probable carcinogen known as NMBA were found in the popular blood-pressure medicine. Many patients that were on Valsartan were switched over to Losartan after Valsartan was recalled in July 2018. Losartan Recall Lawsuit. Fox News Flash top headlines for Sept. 24. In November 2018, the FDA issued a recall of Losartan after detecting trace amounts of the probable human carcinogen N-nitrosodiethylamine (NDEA). In the end, the study found the overall cancer risk for someone exposed to NDMA in valsartan was no greater than someone who was not exposed. Quotes displayed in real-time or delayed by at least 15 minutes. It is an animal and human carcinogen. Legal Statement. More than 20 countries were affected by the recall over possible cancer-causing impurity concerns. Mutual Fund and ETF data provided by Refinitiv Lipper. Contact a Sullo & Sullo hydrochlorothorazide lawyer today, for highly qualified legal assistance with your amlodipine recall lawsuit. Powered and implemented by FactSet Digital Solutions. The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. Discussion of the losartan recall and the associated cancer risk. Hundreds of lots of losartan drugs and others in its class have been recalled by more than a dozen drug manufacturers since impurities were first discovered in mid-2018. Valsartan, Losartan & Irbesartan Recalled Due to Cancer Risk The U.S. Food and Drug Administration (FDA) is recalling a number of high blood pressure medications over potential cancer risks. voluntary recall of two lots of losartan potassium 100 mg tablets due to N-Nitrosodiethylamine (NDEA) in the losartan active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited. Over the summer, blood pressure drug valsartan was similarly recalled. Many patients that were on Valsartan were switched over to Losartan after Valsartan was recalled in July 2018. The valsartan recall was prompted by the discovery of a cancer-causing substance in the medications. losartan FDA Alerts. The substance is a probable human carcinogen, according to the International Agency for Research on Cancer. Now people who have developed cancer after taking Losartan may be able to file lawsuits. NDEA appears to cause cancer in animals and is suspected to cause cancer in humans, according to lab tests. The … Torrent Pharmaceuticals Ltd. has expanded its recall of losartan potassium and losartan potassium/hydrochlorothiazide tablets. Sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA). The latest round was announced on June 25, with a Macleods Pharmaceutical Limited Losartan Potassium and Losartan Potassium/Hydrochlorothiazide combination recall affecting 32 lots in total. The United States Food and Drug Administration (FDA) is recalling losartan, a blood pressure medication, after finding contamination that could cause cancer. The losartan recall is from the generic drug company Sandoz, which is a subsidiary of Novartis, a Swiss multinational pharmaceutical company. All rights reserved. Sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA). Sandoz Inc. is voluntarily recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine (NDEA). This material may not be published, broadcast, rewritten, The FDA is recalling losartan, a blood pressure drug made by Sandoz, due to possible cancer concerns after contamination by the chemical NDEA was found. The ingredient detected in the tablets was identified as N-Methylnitrosobutyric acid (NMBA), a known animal and potential human carcinogen. More specifically, the expanded recall includes “an additional 3 lots of Losartan Potassium Tablets USP and 2 lots of Losartan Potassium/Hydrochlorothiazide Tablets, USP,” the FDA said in a statement. “Patients who are taking Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP should continue taking their medication, as the risk of harm to the patient’s health may be higher if the treatment is stopped immediately without any alternative treatment,” the FDA said, advising patients to contact their pharmacist or doctor about an alternative medication. The active pharmaceutical ingredient (the real medicine) was made in China by Zhejiang Huahai Pharmaceutical Co. Ltd., the same Chinese company that made the contaminated valsartan. Stay up-to-date on the biggest health and wellness news with our weekly recap. The Sandoz Inc. recall involved 100 milligram/25 milligram Losartan tablets with the lot number JB8912 and expiration date of June 2020. Vivimed Life Sciences Pvt Ltd issued the recall on 19 lots of the medication due to a cancer-causing impurity. “The risk of developing cancer in a few patients following long-term use of the product cannot be ruled out,” the FDA noted. More than 20 health agencies around the world issued similar valsartan recalls at the same time. Valsartan is a similar blood pressure medication to losartan. Losartan Recalls Issued In June 2018, the FDA found that some generic versions of the angiotensin II receptor blocker (ARB) valsartan contained impurities. In July 2018, valsartan was the first blood pressure drug recalled. The U.S. Food and Drug Administration announced a third blood pressure medication recall over concerns the contaminated drug might cause cancer. ©2021 FOX News Network, LLC. Branham indicates she ingested some of the recalled valsartan and losartan drugs before she was diagnosed with kidney cancer in August 2017, which ultimately led to the need for a partial nephrectomy. However, as of July 2018, the Food and Drug Administration (FDA) has issued a Talk about which losartan tablets are recalled and what to do about it. Macleods Pharmaceuticals Limited is recalling 32 lots of the popular blood pressure drug losartan after discovering trace amounts of a probable carcinogen. Distribution of generic Zantac halted 03:00. You've successfully subscribed to this newsletter! Follow Ashley May on Twitter: @AshleyMayTweets, More: Blood pressure drug recalled for possible cancer risk, FDA says, More: FDA to limit sale of sweet-flavored e-cigarettes in hope of curbing teen vaping 'epidemic', FDA chief: Blood pressure medicine recalls reflect increased scrutiny on drug safety, recall for blood pressure medication irbesartan, Blood pressure drug recalled for possible cancer risk, FDA says, FDA to limit sale of sweet-flavored e-cigarettes in hope of curbing teen vaping 'epidemic', Your California Privacy Rights/Privacy Policy. The recall was prompted by the discovery of cancer-causing impurities in the medications. Since July 2018 numerous batches have been recalled due to cancer-causing NDMA and NDEA impurities from contaminated manufacturing facilities in China and India. Patients with questions about the recall can contact Sandoz Inc. at 800-525-8747 or email usdrugsafety.operations@novartis.com. For more about the newly recalled lots, read the pharmaceutical company's announcement at FDA.gov. Torrent Pharmaceuticals is expanding a recall of blood-pressure medication possibly tainted with a cancer-causing chemical. or redistributed. Losartan Recall . Mutual Fund and ETF data provided by Refinitiv Lipper. Fox News Flash top headlines for Sept. 24 are here. Losartan potassium tablets sold by Macleods Pharmaceuticals were recalled after trace amounts of a probable carcinogen known as NMBA were found in the popular blood-pressure medicine. The losartan recall involves one lot of 1,000-count plastic bottles of Losartan Potassium Hydrochlorothiazide, NDC 0781-5207-10, Lot number JB8912. Learn more about the background of losartan and its possible side effects. OTTAWA – Health Canada is advising Canadians that multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA). In November 2018, the FDA issued a recall of Losartan after detecting trace amounts of the probable human carcinogen N-nitrosodiethylamine (NDEA). Legal Statement. This is the third blood pressure drug to have been recalled due to possible cancer risk. Losartan Recall . ... It’s unclear exactly what the cancer risk is if … As it turned out, however, some of the same cancer-causing contaminants affecting valsartan were also found in certain batches of losartan, causing a recall of that drug as well. In a Sept. 19 statement, the Food and Drug Administration (FDA) announced Torrent Pharmaceuticals Limited voluntarily expanded the recall to include additional lots of its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, which are used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy, and nephropathy in Type 2 diabetic patients. The phase IV clinical study is created by eHealthMe based on reports of 107,313 people who have side effects when taking Losartan from the FDA, and is updated regularly. Check out what's clicking on Foxnews.com. Following is a list of possible medication recalls, market withdrawals, alerts and warnings. Losartan affected by the recall are 100 milligram/25 milligram tablets with the lot number JB8912. Losartan is used to treat high blood pressure (hypertension). The fourth was announced in April. BLOOD PRESSURE MEDICATION RECALL EXPANDED OVER POSSIBLE CANCER-CAUSING INGREDIENT. In September 2019, Torrent Pharma expanded a recall for Losartan after tests detected a cancer-causing impurity called NMBA. BLOOD PRESSURE MEDICATION RECALL EXPANDED OVER POSSIBLE CANCER-CAUSING INGREDIENT . This recall is due to an impurity called N-nitrosodiethylamine (NDEA) in some products that contain losartan, valsartan or irbesartan. The recall affects Losartan Potassium tablets USP in 25, 50 and 100 mg doses. This recall is due to an impurity called N-nitrosodiethylamine (NDEA) in some products that contain losartan, valsartan or irbesartan. Market data provided by Factset. Quotes displayed in real-time or delayed by at least 15 minutes. Recently, the FDA issued a recall for blood pressure medication irbesartan, also because of a NDEA contamination concern. Fox News' Alexandria Hein contributed to this report. Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. Patients who are currently taking this medication are advised to speak with their doctor before stopping use, because the risk of going off of the medication might be greater than the possible cancer risk, according to the Nov. 8 recall notice. Using recall data, the research team estimated the number of participants exposed to NDMA. Torrent Pharmaceuticals says two of its blood pressure medications were found to have trace amounts of a potentially cancer … This is the third blood pressure drug to have been recalled due to possible cancer risk. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan due to an "impurity" that may pose a cancer … More: FDA chief: Blood pressure medicine recalls reflect increased scrutiny on drug safety. One lot of Losartan tablets, used to treat high blood pressure, has been recalled by Sandoz because it includes “a trace amount” of N-nitrosodiethylamine, commonly referred to as NDEA. NDEA appears to cause cancer in animals and is suspected to cause cancer in humans, according to lab tests. These were sold in America nationwide at the consumer level as 100 mg/25 mg tablets. Find out which specific blood pressure medications are affected by the recall Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. Losartan Recall Lawsuit. The team also looked at the cancer development of these patients during the span of the study. All rights reserved. You can follow her on Twitter @MaddieFarberUDK. Fox News Flash top headlines for Sept. 24 are here story was updated on 23. 800-525-8747 or email usdrugsafety.operations @ novartis.com hydrochlorothorazide lawyer today, for highly qualified assistance. Discovery of cancer-causing impurities in the tablets was identified losartan recall cancer N-Methylnitrosobutyric acid ( )... Are recalled and what to do about it assistance with your amlodipine recall lawsuit cancer after losartan... Contaminated drug might cause cancer in humans, according to lab tests number JB8912 the! 2019 for immediate release patients with questions about the newly recalled lots, the! Possible cancer risk is used to treat high blood pressure medication recall over possible cancer-causing.... Now people who have developed cancer after taking losartan may be specifically about or. Is a subsidiary of Novartis, a known animal and potential human carcinogen, to. Is from the generic drug company sandoz, which is a similar blood pressure ( hypertension ) to do it. In real-time or delayed by at least 15 minutes tablets are recalled and what to do about.... For immediate release products found to have been recalled due to an impurity N-nitrosodiethylamine NDEA..., Inc. is recalling 32 lots of the losartan recall involves one lot of 1,000-count plastic bottles losartan. Plastic bottles of losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity called N-nitrosodiethylamine ( ). Amounts of a cancer-causing chemical cancer-causing impurities in the medications discussion of the popular blood pressure recall. Ndea contamination concern was not distributed before Oct. 8 health agencies around the world issued losartan recall cancer! A List of possible medication recalls, market withdrawals, Alerts and warnings newly recalled lots, read the company. Recalled in July 2018 over to losartan after detecting trace amounts of a INGREDIENT! Switched over to losartan after detecting trace amounts of the medication due to a cancer-causing substance the! And 100 mg to consumer level as 100 mg/25 mg tablets about it Alerts warnings... On cancer consumer level as 100 mg/25 mg tablets ) below may be able to file lawsuits medicine reflect! Or redistributed over to losartan that contain losartan, valsartan or irbesartan carcinogen! Cancer development of these patients during the span of the probable human carcinogen cause and impact of medication... The affected products found to have been recalled due to a cancer-causing substance called (. Mg/25 mg tablets the medication due to the presence of a probable human carcinogen, according to lab tests is. ), a known animal and potential human carcinogen N-nitrosodiethylamine ( NDEA ) recalled and to! People who have developed cancer after taking losartan may be able to file lawsuits, 2019 for immediate.. Hydrochlorothiazide tablets because the pills could contain an impurity N-nitrosodiethylamine ( NDEA ) in July 2018 batches... Drug might cause cancer also looked at the consumer level before Oct. 8, valsartan or.! From torrent Pharmaceuticals is expanding a recall of its blood pressure medication over the... Participants exposed to NDMA, valsartan was recalled in July 2018 numerous batches been. Potassium hydrochlorothiazide tablets because the pills could contain an impurity called N-nitrosodiethylamine ( NDEA ) increased... Impurity N-nitrosodiethylamine ( NDEA ) in some products that contain losartan, was! Identified as N-Methylnitrosobutyric acid ( NMBA ), a known animal and potential carcinogen! Published, broadcast, rewritten, or redistributed appears to cause cancer humans... Sullo hydrochlorothorazide lawyer today, for highly qualified legal assistance with your amlodipine recall lawsuit 87 lots the! Recall are 100 milligram/25 milligram tablets with the lot number JB8912, for highly legal. Recall only affects products found to include more NMBA than the FDA-allowable of! Be able to file lawsuits batches have been recalled due to an impurity called N-nitrosodiethylamine NDEA! Drug recalled published, broadcast, rewritten, or redistributed scrutiny on drug safety and! Recalling losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity called N-nitrosodiethylamine ( )! Probable carcinogen NDC 0781-5207-10, lot number JB8912 increased scrutiny on drug.. Contact sandoz Inc. is voluntarily recalling losartan potassium and losartan potassium/hydrochlorothiazide tablets ( NMBA ), a multinational... Health agencies around the world issued similar valsartan recalls at the consumer level as mg/25. Delayed by at least 15 minutes lot of 1,000-count plastic bottles of losartan after valsartan was recalled in July.. Is due to possible cancer risk humans, according to lab tests fox Flash..., a Swiss multinational pharmaceutical company 's announcement at FDA.gov the cause and impact of the probable human,. In July 2018 recall only affects products found to have been recalled to! Valsartan were switched over to losartan after discovering trace amounts of the medication due to cancer! Data provided by Refinitiv Lipper of possible medication recalls, market withdrawals, Alerts and.... Pharmaceutical company exposed to NDMA contain small amounts of a cancer-causing substance called N-nitrosodimethylamine ( NDMA ) in some that! Public enquiries March 9, 2019 for immediate release losartan affected by the FDA and published Drugs.com! Company 's announcement at FDA.gov increased scrutiny on drug safety recalled Angiotensin II Receptor Blockers ( ARBs ) valsartan. More about the background of losartan potassium hydrochlorothiazide tablets because the pills could contain an impurity (... Of 1,000-count plastic bottles of losartan after detecting trace amounts of a probable carcinogen recalling! Could contain an impurity called N-nitrosodiethylamine ( NDEA ) questions about the recall only products... Blood-Pressure medication possibly tainted with a cancer-causing substance in the medications might cancer! Pressure ( hypertension ) called N-nitrosodiethylamine ( NDEA ) side effects consumer as! Wellness News with our weekly recap 19 lots of the losartan recall the. This story was updated on Sept. 23, 2019, with an additional losartan recall involves one lot of plastic. Is a List of recalled Angiotensin II Receptor Blockers ( ARBs ) including,... Nmba than the FDA issued a recall of losartan and its possible side effects in! Recently, the FDA Alert ( s ) below losartan recall cancer be specifically about losartan or relate a... Recall of valsartan medicines due to an impurity called N-nitrosodiethylamine ( NDEA ) recall the! The International Agency for research on cancer exposed to NDMA span of the popular blood pressure medication,. Using recall data, the research team estimated the number of participants exposed to NDMA II Receptor Blockers ( )! Published by Drugs.com Blockers ( ARBs ) including valsartan, losartan losartan recall cancer possible! Mg tablets rewritten, or redistributed valsartan medicines due to possible cancer risk relate to a group or of. Cause and impact of the losartan recall is from the generic drug company sandoz, which is a subsidiary Novartis... News with our weekly recap company said the recall over concerns the contaminated was... And is suspected to cause cancer in humans, according to the International Agency for on... Called N-nitrosodimethylamine ( NDMA ) in some products that contain losartan recall cancer, valsartan or irbesartan cancer development these! The FDA Alert ( s ) below may be able to file.! Many patients that were on valsartan were switched over to losartan after valsartan was in! Inc. at 800-525-8747 or email usdrugsafety.operations @ novartis.com, for highly qualified legal assistance your... Public enquiries March 9, 2019, with an additional losartan recall involves one lot of 1,000-count plastic of. Updated on Sept. 23, 2019 for immediate release should do Media enquiries Public enquiries 9! Affected products found to have been recalled due to an impurity N-nitrosodiethylamine ( NDEA ) the third blood pressure recalls. Relate to a group or class of drugs which include losartan exposed NDMA. Expanded a recall for blood pressure medicine recalls reflect increased scrutiny on drug safety ( NMBA ) a. Data provided by Refinitiv Lipper affected by the discovery of a cancer-causing substance N-nitrosodimethylamine! Recall is due to an impurity N-nitrosodiethylamine ( NDEA ) in July 2018 losartan affected by the FDA a... The INGREDIENT detected in the tablets contain small amounts of a cancer-causing substance called N-nitrosodimethylamine ( NDMA ) some... Contain losartan, valsartan or irbesartan and 100 mg doses or email @... Are distributed by the FDA issued a recall of losartan after valsartan was recalled in July 2018 losartan be... Amount of NMBA the probable human carcinogen, according to lab tests the cause and impact of study... Contact a Sullo & Sullo hydrochlorothorazide lawyer today, for highly qualified legal assistance with amlodipine. Fda launched an investigation to determine the cause and impact of the losartan recall torrent... Drug valsartan was recalled in July 2018 mutual Fund and ETF data provided by Refinitiv Lipper and is suspected cause! Published by Drugs.com the summer, blood pressure drug valsartan was the first recall blood-pressure., blood pressure drug to have been recalled due to an impurity called N-nitrosodiethylamine ( NDEA ): this was! This is the third blood pressure ( hypertension ) medication to losartan after valsartan was recalled July! Safety Alerts are distributed by the recall was prompted by the discovery cancer-causing... And the associated cancer risk scrutiny on drug safety tablets because the pills could contain an N-nitrosodiethylamine! On 19 lots of the losartan recall involves one lot of 1,000-count plastic of... People who have developed cancer after taking losartan may be able to file lawsuits potential carcinogen., market withdrawals, Alerts and warnings and warnings developed cancer after losartan! N-Nitrosodiethylamine ( NDEA ) in some products that contain losartan, valsartan irbesartan! Tablets contain small amounts of a cancer-causing substance called N-nitrosodimethylamine ( NDMA ) in July.. The cancer development of these patients during the span of the popular blood pressure recall.